IL13 and asthma: Recently, ILC2s, which constitute an early source of T2 cytokines in asthma, were shown to induce increased epithelial barrier permeability and reduced expression of epithelial tight junction proteins via secretion of IL-13 in an ALI-coculture model of human bronchial epithelial cells (HBECs) and ILC2s [65].